HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Subcutaneous sumatriptan does not abort attacks of chronic paroxysmal hemicrania (CPH).

AuthorsC Dahlöf
JournalHeadache (Headache) Vol. 33 Issue 4 Pg. 201-2 (Apr 1993) ISSN: 0017-8748 [Print] United States
PMID8388371 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Indoles
  • Serotonin Receptor Agonists
  • Sulfonamides
  • Sumatriptan
Topics
  • Adult
  • Humans
  • Indoles (therapeutic use)
  • Male
  • Migraine Disorders (drug therapy)
  • Serotonin Receptor Agonists (therapeutic use)
  • Sulfonamides (therapeutic use)
  • Sumatriptan

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: